Glycan Diversity and Anti-Glycan Antibodies as Barriers to Gene Flow

聚糖多样性和抗聚糖抗体作为基因流的障碍

基本信息

  • 批准号:
    8901198
  • 负责人:
  • 金额:
    $ 29.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-15 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glycan Diversity and Anti-Glycan Antibodies as Barriers to Gene Flow Mammalian cells are covered with a dense layer of sugar chains (glycans). Patterns of glycan diversity exist between cell types, between individuals, and between species. The evolutionary mechanisms underlying such patterns remain unknown but protective functions of glycan diversity have been proposed, given that non-self glycans are targets of innate and adaptive immunity. Mammalian glycans commonly terminate in sugars called sialic acids (Sias). The two most common Sias are N-Acetylneuraminic acid (Neu5Ac) and N- Glycolylneuraminic acid (Neu5Gc). Humans have lost the ability to produce Neu5Gc from its precursor Neu5Ac due to a gene inactivation. Humans together with all other old world monkeys (OWM) and apes have lost the ability to make another common glycan, the α-Gal epitope, due to another mutation. The molecular cell surface "landscape" of each human cell thus differs from those of most other mammals by lacking millions of α-Gal molecules and tens of millions of Neu5Gc molecules. Humans also make antibodies to both of these "xenoglycans" but how we get immunized remains unknown. This project will test the effect of these two xenoglycans on different forms of gene flow, viral infection and reproduction. Humans are unique among African primates for lacking endemic infection and ancient coevolution with two different enveloped retroviruses, immune deficiency viruses (SIV/HIV) and foamy viruses (SFV) until very recently. Glycans on enveloped viruses or sperm and fetal tissues can be targeted by the immune system. We propose that natural selection by glycan-binding pathogens may underlie initial glycan diversification, but that sexual selection in the form reproductive incompatibility may lead to fixation of glycan repertoires between species. In the process, these glycan differences provide partial protection from cross-species transmission of enveloped viruses. We will utilize gene knockout mice and mouse cell lines to test the effect of glycan mismatch and anti-glycan antibodies on both, viral and reproductive gene flow. We will also test the effect of anti-glycan antibodies from human sera for their neutralizing effects on viruses produced in Old and New World monkey cell lines which naturally differ in their xenoglycan profiles. This project promises important insights into the mechanism of poorly understood glycan evolution, reproductive compatibility and determinants of cross-species viral infections.
描述(由申请人提供):作为基因流动障碍的葡聚糖多样性和抗葡聚糖抗体哺乳动物细胞被一层致密的糖链(葡聚糖)覆盖。不同的细胞类型、不同的个体和不同的物种之间存在着不同的糖链多样性模式。这种模式背后的进化机制尚不清楚,但鉴于非自体多糖是先天免疫和获得性免疫的靶标,已提出了糖链多样性的保护功能。哺乳动物的糖链通常终止于一种叫做唾液酸(SIA)的糖类中。两种最常见的SIA是N-乙酰神经氨酸(Neu5Ac)和N-羟基神经氨酸(Neu5Gc)。由于基因失活,人类已经失去了从其前体Neu5Ac产生Neu5Gc的能力。由于另一种突变,人类以及所有其他东半球猴子和类人猿已经失去了制造另一种常见的糖链--α-Gal表位的能力。因此,每个人类细胞的分子细胞表面“景观”与大多数其他哺乳动物的不同之处在于缺乏数以百万计的α-Gal分子和数千万个Neu5Gc分子。人类也会对这两种“异聚糖”产生抗体,但我们是如何获得免疫的还不清楚。该项目将测试这两种异聚糖对不同形式的基因流动、病毒感染和繁殖的影响。人类在非洲灵长类动物中是独一无二的,因为人类缺乏地方性感染,并且直到最近才与两种不同的包膜逆转录病毒-免疫缺陷病毒(SIV/HIV)和泡沫病毒(SFV)-共同进化。被包裹的病毒或精子和胎儿组织上的葡聚糖可以成为免疫系统的靶标。我们认为,糖链结合病原体的自然选择可能是最初糖链多样化的基础,但生殖不亲和性选择可能导致不同物种之间的糖链酶谱固定。在这个过程中,这些多糖的差异提供了部分保护,使其免受包膜病毒跨物种传播的影响。我们将利用基因敲除小鼠和小鼠细胞系来测试糖链错配和抗糖链抗体对病毒和生殖基因流的影响。我们还将测试来自人血清的抗多糖抗体对新旧世界猴子细胞系产生的病毒的中和作用,这两种细胞系的异聚糖图谱自然不同。该项目有望对尚不清楚的多糖进化机制、繁殖亲和性和跨物种病毒感染的决定因素提供重要的见解。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evolution of genetic and genomic features unique to the human lineage.
Reply to Liu and Jiang: Maintenance of postreproductive cognitive capacity by inclusive fitness.
回复刘和江:包容性健身维持生育后认知能力。
Glycomics: revealing the dynamic ecology and evolution of sugar molecules.
  • DOI:
    10.1016/j.jprot.2015.11.022
  • 发表时间:
    2016-03-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Springer SA;Gagneux P
  • 通讯作者:
    Gagneux P
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pascal Gagneux其他文献

Pascal Gagneux的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pascal Gagneux', 18)}}的其他基金

Glycan array for phenotype-driven capture and genotyping of viruses in primary isolates
用于对初级分离株中的病毒进行表型驱动捕获和基因分型的聚糖阵列
  • 批准号:
    9167135
  • 财政年份:
    2016
  • 资助金额:
    $ 29.11万
  • 项目类别:
Glycan Diversity and Anti-Glycan Antibodies as Barriers to Gene Flow
聚糖多样性和抗聚糖抗体作为基因流的障碍
  • 批准号:
    8653968
  • 财政年份:
    2011
  • 资助金额:
    $ 29.11万
  • 项目类别:
Glycan Diversity and Anti-Glycan Antibodies as Barriers to Gene Flow
聚糖多样性和抗聚糖抗体作为基因流的障碍
  • 批准号:
    8470186
  • 财政年份:
    2011
  • 资助金额:
    $ 29.11万
  • 项目类别:
Glycan Diversity and Anti-Glycan Antibodies as Barriers to Gene Flow
聚糖多样性和抗聚糖抗体作为基因流的障碍
  • 批准号:
    8298057
  • 财政年份:
    2011
  • 资助金额:
    $ 29.11万
  • 项目类别:
Glycan Diversity and Anti-Glycan Antibodies as Barriers to Gene Flow
聚糖多样性和抗聚糖抗体作为基因流的障碍
  • 批准号:
    8115644
  • 财政年份:
    2011
  • 资助金额:
    $ 29.11万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 29.11万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 29.11万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 29.11万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 29.11万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 29.11万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 29.11万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 29.11万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 29.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 29.11万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 29.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了